Cargando…
Reanalysis of the Multi‐Biomarker Disease Activity Score for Assessing Disease Activity in the Abatacept Versus Adalimumab Comparison in Biologic‐Naive Rheumatoid Arthritis Subjects with Background Methotrexate Study: Comment on the Article by Fleischmann et al
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749941/ https://www.ncbi.nlm.nih.gov/pubmed/27813312 http://dx.doi.org/10.1002/art.39981 |
| _version_ | 1783452378083622912 |
|---|---|
| author | Curtis, Jeffrey R. Wright, Grace C. Strand, Vibeke Davis, Charles S. Hitraya, Elena Sasso, Eric H. |
| author_facet | Curtis, Jeffrey R. Wright, Grace C. Strand, Vibeke Davis, Charles S. Hitraya, Elena Sasso, Eric H. |
| author_sort | Curtis, Jeffrey R. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6749941 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-67499412019-09-23 Reanalysis of the Multi‐Biomarker Disease Activity Score for Assessing Disease Activity in the Abatacept Versus Adalimumab Comparison in Biologic‐Naive Rheumatoid Arthritis Subjects with Background Methotrexate Study: Comment on the Article by Fleischmann et al Curtis, Jeffrey R. Wright, Grace C. Strand, Vibeke Davis, Charles S. Hitraya, Elena Sasso, Eric H. Arthritis Rheumatol Letters John Wiley and Sons Inc. 2017-03-03 2017-04 /pmc/articles/PMC6749941/ /pubmed/27813312 http://dx.doi.org/10.1002/art.39981 Text en © 2016 The Authors. Arthritis & Rheumatology published by Wiley Periodicals, Inc. on behalf of American College of Rheumatology. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letters Curtis, Jeffrey R. Wright, Grace C. Strand, Vibeke Davis, Charles S. Hitraya, Elena Sasso, Eric H. Reanalysis of the Multi‐Biomarker Disease Activity Score for Assessing Disease Activity in the Abatacept Versus Adalimumab Comparison in Biologic‐Naive Rheumatoid Arthritis Subjects with Background Methotrexate Study: Comment on the Article by Fleischmann et al |
| title | Reanalysis of the Multi‐Biomarker Disease Activity Score for Assessing Disease Activity in the Abatacept Versus Adalimumab Comparison in Biologic‐Naive Rheumatoid Arthritis Subjects with Background Methotrexate Study: Comment on the Article by Fleischmann et al |
| title_full | Reanalysis of the Multi‐Biomarker Disease Activity Score for Assessing Disease Activity in the Abatacept Versus Adalimumab Comparison in Biologic‐Naive Rheumatoid Arthritis Subjects with Background Methotrexate Study: Comment on the Article by Fleischmann et al |
| title_fullStr | Reanalysis of the Multi‐Biomarker Disease Activity Score for Assessing Disease Activity in the Abatacept Versus Adalimumab Comparison in Biologic‐Naive Rheumatoid Arthritis Subjects with Background Methotrexate Study: Comment on the Article by Fleischmann et al |
| title_full_unstemmed | Reanalysis of the Multi‐Biomarker Disease Activity Score for Assessing Disease Activity in the Abatacept Versus Adalimumab Comparison in Biologic‐Naive Rheumatoid Arthritis Subjects with Background Methotrexate Study: Comment on the Article by Fleischmann et al |
| title_short | Reanalysis of the Multi‐Biomarker Disease Activity Score for Assessing Disease Activity in the Abatacept Versus Adalimumab Comparison in Biologic‐Naive Rheumatoid Arthritis Subjects with Background Methotrexate Study: Comment on the Article by Fleischmann et al |
| title_sort | reanalysis of the multi‐biomarker disease activity score for assessing disease activity in the abatacept versus adalimumab comparison in biologic‐naive rheumatoid arthritis subjects with background methotrexate study: comment on the article by fleischmann et al |
| topic | Letters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749941/ https://www.ncbi.nlm.nih.gov/pubmed/27813312 http://dx.doi.org/10.1002/art.39981 |
| work_keys_str_mv | AT curtisjeffreyr reanalysisofthemultibiomarkerdiseaseactivityscoreforassessingdiseaseactivityintheabataceptversusadalimumabcomparisoninbiologicnaiverheumatoidarthritissubjectswithbackgroundmethotrexatestudycommentonthearticlebyfleischmannetal AT wrightgracec reanalysisofthemultibiomarkerdiseaseactivityscoreforassessingdiseaseactivityintheabataceptversusadalimumabcomparisoninbiologicnaiverheumatoidarthritissubjectswithbackgroundmethotrexatestudycommentonthearticlebyfleischmannetal AT strandvibeke reanalysisofthemultibiomarkerdiseaseactivityscoreforassessingdiseaseactivityintheabataceptversusadalimumabcomparisoninbiologicnaiverheumatoidarthritissubjectswithbackgroundmethotrexatestudycommentonthearticlebyfleischmannetal AT davischarless reanalysisofthemultibiomarkerdiseaseactivityscoreforassessingdiseaseactivityintheabataceptversusadalimumabcomparisoninbiologicnaiverheumatoidarthritissubjectswithbackgroundmethotrexatestudycommentonthearticlebyfleischmannetal AT hitrayaelena reanalysisofthemultibiomarkerdiseaseactivityscoreforassessingdiseaseactivityintheabataceptversusadalimumabcomparisoninbiologicnaiverheumatoidarthritissubjectswithbackgroundmethotrexatestudycommentonthearticlebyfleischmannetal AT sassoerich reanalysisofthemultibiomarkerdiseaseactivityscoreforassessingdiseaseactivityintheabataceptversusadalimumabcomparisoninbiologicnaiverheumatoidarthritissubjectswithbackgroundmethotrexatestudycommentonthearticlebyfleischmannetal |